Wegovy Users Maintain Weight Loss for 4 Years: Here's How It Works

Updated Dec 3, 2024 | 09:00 PM IST

SummaryWegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving weight-loss drug Wegrovy sustained weight loss for up to four years
wegovy

wegovy (Credit: Canva)

People receiving weight-loss drug Wegovy sustained weight loss for up to four years, shedding an average of 10% of their body weight in that time, as per a new study. Wegrovy is a brand that markets semaglutide injections, that have gained widespread attention for their weight-loss effects. The study also found that Semaglutide injections boost an individual's heart health, even when weight loss doesn't take place.

The study, called SELECT, was published in journal Nature Medicine. "At four years, we see ongoing benefits of semaglutide," said Cheng-Han Chen, MD, interventional cardiologist from Cardiologist, who was not involved in the research. Besides the weight loss, it also lead to a loss in cardiovascular outcomes.

The research was conducted on 17000 adults, who had obesity but did not have diabetes. Overall, people who received once-weekly injections of semaglutide lost on average 10.2% of their body weight over the course of four years. All of the study participants continued to lose weight for about 65 weeks, a year and three months, and then their weight remained at a stable level.

Were There Any Side Effects?

However, people's experience with the medication varied. Researchers found no unexpected safety issues with drug during trial. In fact, most the people who withdrew from the study were those who experienced the known symptsoms of the semaglutide injections like nausea, indigestion etc. This occurred mainly during the beginning of the study, as the dose of the medicine is increased to a maximally tolerated dose.

What Did The Results Say?

Of the people on the highest dose of Wegovy, 68% lost at least 5% of their body weight. This compared to 21% of people on the placebo. Additionally, of the total people on Wegovy about 23% lost at least 15% of their body weight. For those in the placebo group, only 1.7% lost that much body weight.

Semaglutide Shows Heart Benefits Beyond Weight Loss

Researchers found that even individuals who did not experience significant weight reduction while on the drug saw a reduced risk of major heart events. Recent analysis of the SELECT trial data revealed that semaglutide significantly lowers the risk of heart attack, stroke, and cardiovascular-related deaths in adults with obesity or those who are overweight. Notably, the results of this study lead the US FDA to approve Novo Nordisk's Wegovy for reducing heart-related risks in this group.

What Is Semaglutide?

Semglutide is the synthetic version of GLP-1—a natural hormone produced in the intestines that regulates blood sugar, appetite, and digestion. Now, every time you eat, your body produces various hormones, including GLP-1. These are called Post nutrition hormones, and help you absorb the energy you just consumed. GLP-1 travels to your pancreas, prompting it to produce insulin. It also travels to the hypothalamus in your brain, which gives you the feeling of being full or satiated. Ozempic imitates this hormone, thereby, silencing the food chatter in the brain. Interestingly, for some people this food chatter is really quiet ( people with low appetite) and for others it is an outburst, (people who generally binge eat.) So with Ozempic, silencing this self-talk in the brain, people tend to lose their appetite and eventually weight.

Are Their Any Side Effects Of Semaglutide?

Semaglutide, marketed under the brand name Wegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. It is also an anti-obesity drug used for long-term weight management. While it can be taken as a subcutaneous injection or orally, it has significant side effects. It primarily impacts your gastrointestinal tract and its side effects include constipation, nausea, abdominal pain, diarrhoea, and fatigue amongst others.

End of Article

Why COPD Is Now Affecting People in Their 20s and 30s

Updated Nov 19, 2025 | 07:00 PM IST

SummaryCOPD is increasingly affecting people in their 20s and 30s, driven more by toxic exposures than smoking. Doctors warn that pollution, biomass fuel, vaping, childhood lung infections, and occupational hazards are accelerating lung damage. Early symptoms like persistent cough or breathlessness must not be ignored, as early diagnosis can slow long-term decline.
Why COPD Is Now Affecting People in Their 20s and 30s

Credits: Canva

Chronic obstructive pulmonary disease (COPD) has long been seen as a condition of older adults, typically tied to years of smoking. But across India, pulmonologists are increasingly diagnosing it in people in their 20s and 30s. This shift, experts say, reflects a deeper and more troubling change: young adults are growing up and living in environments where the lungs never truly get a chance to breathe clean air.

A Shift From “Smoker’s Disease” to “Exposure Disease”

The biggest change is the cause itself. As Dr. Raja Dhar, Director & HOD, Pulmonology, CK Birla Hospitals, CMRI Kolkata, explains, “COPD is increasingly becoming an ‘exposure disease’ rather than a ‘smoker’s disease.’ In India, non-smoking COPD is numerically a much larger problem.”

This exposure begins early—sometimes in childhood.

Dr. Dhar highlights how even limited exposure can have lifelong consequences: “Severe airway obstruction can be traced back to just six to seven years of biomass smoke exposure in a poorly ventilated kitchen during a child’s formative years.”

Dr. Harshil Alwani, Consultant – Pulmonology, CK Birla Hospitals, Jaipur, also points to the changing risk profile. According to him, “newer epidemiological data show that non-smoking drivers—especially air pollution and occupational exposures—are playing a disproportionately large role in younger people.” He adds that rapid urbanisation means more young adults are chronically breathing polluted air from childhood onwards.

Improved diagnosis and greater awareness also mean younger patients with persistent symptoms are now being evaluated more often, he notes.

Beyond Smoking: The Real Culprits Behind Early COPD

Air Pollution

Both experts agree that polluted air is the biggest trigger today. Dr. Alwani explains that long-term exposure to PM₂.₅ is directly linked to lung decline and COPD. “Recent research shows that temperature and humidity modulate the harmful effect of PM₂.₅, making COPD risk worse under certain climatic conditions,” he says.

Dr. Dhar adds that India’s air quality is deteriorating nationwide: “Ambient outdoor air pollution is a severe risk, as air quality across 98% of India is worse than WHO standards.”

Indoor Pollution

Household pollution remains a massive issue. Biomass fuel used for cooking is, as Dr. Dhar puts it, “the largest non-smoking contributor, resulting in numbers approximately three times that of smoking-related COPD.”

Occupational Hazards

Young adults working in construction, mining, welding, or factory settings face daily exposure to dust, fumes, and chemicals. Dr. Alwani notes that such environments “carry a significantly increased risk.”

Childhood Lung Infections

Recurrent infections can impair lung development and reduce lung reserve, making early-onset disease more likely.

Genetic Factors

Conditions like alpha-1 antitrypsin deficiency, though rare, still contribute when combined with environmental triggers.

Delhi’s Winter Pollution: A Direct Route to Lung Damage

Every winter, Delhi’s smog becomes a health emergency. According to Dr. Dhar, “High winter pollution, particularly hazardous levels of PM2.5, acts as a chronic, low-grade chemical burn on the young respiratory system.”

Dr. Alwani adds that winter inversion traps pollutants closer to the ground, amplifying PM₂.₅’s damage.

The Vaping Problem

Vaping and e-cigarettes, widely perceived as harmless, have added a new layer of risk. Dr. Alwani warns, “Vaping is not benign. Its aerosols contain volatile compounds, heavy metals, and ultrafine particles that trigger inflammation and oxidative stress—central pathways to COPD.”

Dr. Dhar echoes this concern: “Any inhalation of heated chemical aerosols is a significant lung irritant and pro-inflammatory agent.”

Symptoms Young Adults Should Never Ignore

Doctors urge young adults not to dismiss symptoms like:

  • Persistent cough
  • Breathlessness during routine activity
  • Wheezing or chest tightness
  • Frequent colds or bronchitis
  • Fatigue or reduced stamina

Why Early Diagnosis Matters

Early spirometry can dramatically change outcomes. As Dr. Dhar puts it, “Early intervention allows us to remove the source of exposure and start therapy, which can effectively preserve the patient’s remaining lung function.”

Dr. Alwani adds that catching the disease early can “significantly slow further lung damage” and prevent long-term complications.

End of Article

International Men's Day: Millions of Men May Be Living With Undetected Autoimmune Disorders, Know What They Are

Updated Nov 19, 2025 | 01:15 PM IST

SummaryMen’s health often gets overlooked, with men visiting doctors far less than women. This leads to delayed diagnoses, including an estimated 5.7 million men living with undiagnosed autoimmune diseases. Key conditions men should watch for include psoriasis, ankylosing spondylitis, type 1 diabetes, and IBD, all linked to serious long-term risks.
International Men's Day: Millions of Men May Be Living With Undetected Autoimmune Disorders, Know What Are They

Credits: Canva

On International Men's Day, we shift our focus on men's health and why is it important to talk about it. Time and again experts, doctors, and studies have shared how men generally visit GPs less than women. As per the NIH, US, the consultation rate is 32% lower in men than women. The difference is often attributed to a combination of women being more willing to admit sickness and seek help, while cultural factors and barriers for men keep them away from seeking help. However, not anymore, because both sexes require help when they need, especially when it is about their health.

Also Read: The Kessler Twins Die By Assisted Suicide in Germany; How It Differs From Euthanasia

As per a 2024 study published in the Journal of Clinical Investigation, about 5.7 million men could be living with an autoimmune disease that they do not even know about. The disease in men are often overlooked, all thanks to the social barriers.

Sex chromosomes play a key role in predisposing men or women to an autoimmune disease. Females have XX chromosomes, while male have XY chromosome and each chromosome carries gene sequence, which means specific pieces of DNA. Since X chromosome carries a bunch of gene related immunity,, having two of them could explain why women often have a higher rate of autoimmune diseases.

However, men are less likely to book time with their doctors, which could impact the discrepancies between sexes. They could thus often be undiagnosed or could flag their symptoms only when the disease has progressed.

Four Autoimmune Diseases Men Should Be Aware Of

Psoriasis

This is an inflammatory skin condition which affects both men and women. However, studies including the one published in 2023 in the International Journal of Women's Dermatology have suggested that men could develop this condition near their genitals and butt than women.

Also Read: Delhiites, Skip Your Morning Walk, You May Be Inhaling 3x Toxic Air Than Usual, According To Doctor

Ankylosing Spondylitis or AS

As happens due to the inflammation of the spine's joints and ligaments and could cause back pain and stiffness. While the condition is rare in itself, it could affect men more than women, that too at a younger age, usually below 40. A South Korean study from 2018, published in Scientific Reports, AS was 3.6 times more prevalent in men than women.

Type 1 Diabetes

The 2018 report by the Centers for Disease Control and Prevention, (CDC), US, provides data that type 1 diabetes may be slightly more in common in men than women. Though, other studies have been a mixed bag. Unlike type 2 diabetes, type 1 is an autoimmune disease, which means, here immune system attacks are specialized. What men should know is that both types of diabetes could up their risk of erectile dysfunction (ED) due to persistently high blood sugar, which could harm their nerves and blood vessels.

A 2016 study published in the International Journal of Impotence Research found that nearly 60% of 151 men being treated for type 1 diabetes had mild ED.

Inflammatory Bowel Disease (IBD)

The most common forms are Crohn's disease and ulcerative colitis, that take hold of digestive system. Chronic inflammation in the gut spikes the risk of colorectal cancer, which is one of the leading cause of death in men between 20 to 49 of ages. In fact, a 2023 study published in the journal Cancers noted that men with IBD faced a higher risk of developing colorectal cancer than women with IBD.

End of Article

What Does A Black Box Warning On Your Prescription Drug Really Mean?

Updated Nov 19, 2025 | 04:00 AM IST

SummaryA black box warning is the FDA’s strongest safety alert on a prescription drug. Learn what it means, why it’s added, and how it affects the way your medication should be used and monitored. Keep reading for details.
black box warning

Credits: Canva

Not every medicine carries the same level of risk. Some drugs can trigger reactions that are severe or even life-threatening. When that possibility exists, the manufacturer is required to place a special notice inside the prescribing information. This highlighted section is known as a black box warning.

A black box warning is meant to draw clear attention to the most serious dangers linked to a drug. Many medicines fall under this category. Still, having the warning in place does not automatically make the treatment unsafe. When a drug is used correctly and monitored by a trained professional, the benefits may outweigh the risks.

The sections below outline what an FDA black box warning means, why a medicine might receive one, and how it may influence your treatment plan.

What Is An FDA Black Box Warning And What Does It Signify?

A black box warning is the strongest caution that the FDA can attach to a prescription drug. You might also see it described as a boxed warning.

The presence of this warning does not mean a person should never take the medication. Instead, it alerts doctors and patients to serious potential harm. This information helps clinicians decide who is an appropriate candidate and under what circumstances the drug should be used.

Many medicines with boxed warnings remain the best or only option for certain conditions.

How Serious Is A Black Box Warning?

A drug receives this type of label when it has been linked to outcomes such as permanent injury, hospitalisation, or death. These warnings should be read carefully, and patients should discuss them openly with their healthcare provider.

Doctors follow specific precautions when prescribing drugs that carry this label to minimize unnecessary risk.

Where Can I Find A Drug’s Black Box Warning?

The warning sits at the very top of the medication’s official package insert. Its placement is deliberate so it stands out immediately. The text is printed inside a bold black border, which is how the term “black box” took hold.

You may not always receive the full package insert from the pharmacy. However, you might receive a medication guide if the drug is considered high-risk. These guides describe proper use and highlight major side effects. You can also look up medication guides online.

Information about boxed warnings is available from multiple sources. The FDA website, the drug manufacturer’s website, and medical reference sites used by clinicians all include these details.

How Does A Drug End Up With A Black Box Warning?

Every prescription drug must go through extensive testing before it reaches the market. During this process, researchers aim to uncover risks that could require a boxed warning from the start. Even so, some side effects only appear once large numbers of people begin using the drug in everyday settings.

Because of this, most black box warnings are added after a medicine has already been approved. The FDA continues to monitor safety reports through MedWatch, a program where patients, physicians, and companies can report problems.

These reports are gathered in a database called the FDA Adverse Event Reporting System. When the agency notices a pattern of serious reactions, they investigate. If needed, they update the prescribing information and add a boxed warning so that future users are clearly informed.

End of Article